City briefs: Avacta and Proactis
Avacta has signed a distribution agreement with life science products provider Calibre Scientific Inc, for Avacta’s AffiDX® SARS-CoV-2 antigen lateral flow test for professional use in the UK and European Economic Area (EEA).
Calibre is a diversified global provider of life science products to the diagnostics, healthcare, research, industrial, and biopharmaceutical communities.
With headquarters in Los Angeles, California, it has a global reach extending to over 100 countries across a wide array of verticals and geographies.
The non-exclusive distribution agreement for Avacta’s COVID-19 test will be listed on Calibre’s web site and available to be purchased by professional users.
Dr Alastair Smith, chief executive officer of Wetherby-based Avacta Group, said: “As a high quality, global distributor of diagnostics and life science products with excellent links to our target markets, we are confident Calibre is well placed to support our penetration of the professional end use market in the UK and EEA.
“Avacta will continue to focus on developing direct sales opportunities to major corporates and other large scale end users.
“We are also in discussion with potential customers in territories outside the UK and EEA, including some of the APAC region, where the additional regulatory approvals required beyond CE marking are minimal.
“Lateral flow tests have a crucial role to play in helping societies and the global economy return to normal and Avacta’s AffiDX antigen test, developed in the UK and based on UK technology is well placed to play a significant role in this process.
“I look forward to updating the market on progress over the coming months.”
:::
Tim Sykes
Business spend management solution provider, Proactis Holdings, has reached a commercial partnership agreement with EPSA, an international sustainable performance expert.
EPSA operates across 30 countries and is the parent company of Experbuy, the first bePayd customer.
Under the agreement EPSA will market the Proactis early payment service, bePayd, further into the French market. This will extend the market reach of bePayd.
Matthieu Gufflet, founder of EPSA, said: “EPSA strengthens its cash optimisation offer through this partnership. bePayd offers the opportunity to increase operating profitability to buyers and improve supplier working capital solutions. The supply chain is effectively reinforced.”
Tim Sykes, chief executive officer at Wetherby-based Proactis, added: “We are delighted to have agreed this strategic relationship with our partner, EPSA.
“It’s a further validation of Proactis’ value proposition and EPSA’s expertise and reach into the enterprise class French market will help accelerate the deployment and shape of bePayd quickly.“
